Zepbound 10 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FHXCG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $42,726
Award facts
- Contract value 100% obligated
- $42,725.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 mL pen auto-injectors valued at $42,725.87 on June 2, 2025, with completion scheduled for June 3, 2025. This firm fixed-price delivery order is non-competitive and was performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as the primary vehicle for pharmaceutical and medical supply procurement to support military healthcare operations globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that supplies a comprehensive portfolio of pharmaceutical products, medical devices, and healthcare commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract performance demonstrates significant capability in fulfilling diverse medical procurement requirements, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for Zepbound, a diabetes medication, exemplifies the company's role as a preferred vendor for DLA medical supply chain operations, supporting military healthcare needs through the broader pharmaceutical prime vendor program infrastructure.
Quick answers
Who was awarded contract SPE2DB25FHXCG?
SPE2DB25FHXCG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 2, 2025.
How much is contract SPE2DB25FHXCG worth?
The government has obligated $42,726 on SPE2DB25FHXCG.
Is contract SPE2DB25FHXCG an order under another contract?
Yes. SPE2DB25FHXCG is a delivery order under SPE2DB24D2109, an indefinite delivery contract.
Was contract SPE2DB25FHXCG competed?
The extent of competition for SPE2DB25FHXCG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award